Evusheld is the first FDA-authorized drug to prevent COVID-19 in high-risk people who aren’t adequately protected by vaccination alone.
Read moreThe 988 Lifeline will connect callers with specialists trained to assist with mental health crises, including psychotic symptoms and substance...
Read moreThe data supporting Aduhelm are scant at best. But that did not stop its manufacturer from releasing additional data, showing...
Read more“Polina came to our bedroom awakened by the sound of explosions. I didn’t know and still don’t know what to...
Read moreWe see an increasing number of prescriptions for abortion medications - because of increasing access to abortion providers via telemedicine,...
Read moreOver the past two years of living with COVID-19, many churches have had to think in new ways.
Read moreDr. Ruan holds the world record for the most board certifications of any physician. But today he finds himself before...
Read moreThe way we think creates the conclusions we make. Unfortunately, faulty logic has led to failed drug policy. It is...
Read moreMany social factors put women at a higher risk of infection during a pandemic, since women usually assume the role...
Read moreThe CDC released new guidelines for prescribing opioids, offering solace to many patients. But what is not included in the...
Read moreThe Supreme Court ruled against vaccine mandates for large employers. It was an expected ruling that fell along partisan lines....
Read moreThe FDA has authorized multiple COVID treatments, but they remain limited for the foreseeable future due to the belief that...
Read moreSemaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy